| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,380 | 16,757 | 20,025 | 21,979 | | Cost of Revenue | 7,685 | 7,537 | 9,433 | 11,154 | | | Gross Profit | 8,695 | 9,220 | 10,592 | 10,825 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,582 | 1,654 | 1,577 | 1,468 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,902 | 2,935 | 2,958 | 2,828 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,211 | 4,631 | 6,057 | 6,529 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9 | (59) | (47) | (8) | | Earnings Before Interest And Taxes | 4,220 | 4,572 | 6,010 | 6,521 | | Interest Expense | 148 | 154 | 160 | 224 | | Income Before Tax | 4,072 | 4,418 | 5,850 | 6,297 | | Income Tax Expense | 1,429 | 1,546 | 2,053 | 2,365 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,643 | 2,872 | 3,797 | 3,932 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,643 | 2,872 | 3,797 | 3,932 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,643 | $2,872 | $3,797 | $3,932 |
|
1.00% Nasdaq 
Income Statement
